School of Medicine
Showing 481-500 of 666 Results
-
Jianghong Rao
Professor of Radiology (Molecular Imaging Program at Stanford) and, by courtesy, of Chemistry
Current Research and Scholarly InterestsProbe chemistry and nanotechnology for molecular imaging and diagnostics
-
Eduardo Pontes Reis
Affiliate, Rad/Pediatric Radiology
BioI'm a visiting scholar at Stanford AIMI Center, working in the intersection of Artificial Intelligence and Medicine. My purpose is to contribute to our understanding of intelligence. And our best chance to achieve this is through AI.
Research highlights:
- Published BRAX, the Brazilian Chest X-ray Dataset - https://www.nature.com/articles/s41597-022-01608-8
- Open-sourced the PyTorch implementation of ConVIRT (Y Zhang et al), a contrastive learning method for radiologic images and text (before CLIP) - https://github.com/edreisMD/ConVIRT-pytorch
- Released Brain Hemorrhage Annotations - Brain Hemorrhage Extended - BHX (https://physionet.org/content/bhx-brain-bounding-box)
At Hospital Israelita Albert Einstein:
- Started the Health Story project, a medical history timeline to support research and a more personalized clinical practice
- Ran the development of AI algorithms for diseases of national importance: Tuberculosis, COVID, Melanoma and Head CT -
Allan L. Reiss
Howard C. Robbins Professor of Psychiatry and Behavioral Sciences and Professor of Radiology
Current Research and Scholarly InterestsMy laboratory, the Center for Interdisciplinary Brain Sciences Research (CIBSR), focuses on multi-level scientific study of individuals with typical and atypical brain structure and function. Data are obtained from genetic analyses, structural and functional neuroimaging studies, assessment of endocrinological status, neurobehavioral assessment, and analysis of pertinent environmental factors. Our overarching focus is to model how brain disorders arise and to develop disease-specific treatments.
-
Samantha Reyes
Postdoctoral Scholar, Molecular Imaging Program at Stanford
BioResearch Interests: Preclinical and clinical PET imaging, novel tracer validation in vivo, neuroinflammation, proteomics, theranostics and pharmacokinetic modeling
Samantha is an NIH T32 SMIS Postdoctoral Scholar who completed her PhD in Biomedical Physics in Dr. Michelle James' laboratory at Stanford, where her doctoral work focused on the development and translational validation of novel PET radiotracers for non-invasive imaging of neuroinflammation. She led the preclinical development and validation of two GPR84-targeted PET radiotracers for imaging innate immune activation in a murine model of multiple sclerosis, and also led the clinical data analysis for the first whole-body TSPO-PET/MRI study in female patients with ME/CFS. She is well-versed in preclinical and clinical PET quantitation, pharmacokinetic modeling, autoradiography, and cell-based assays. Her postdoctoral research applies her molecular imaging expertise to gynecological cancers, with a focus on using proteomics-driven biomarker discovery and novel theranostic radioligands to characterize the tumor microenvironment and improve response to therapy in women's cancer. -
Eman Rezk
Affiliate, Rad/Integrative Biomedical Imaging Informatics at Stanford
Visiting Postdoctoral Scholar, Rad/Integrative Biomedical Imaging Informatics at StanfordBioPostdoctoral researcher, Royal Society of Canada award recipient, and NSERC scholar, specializing in AI-driven healthcare solutions with a focus on equitable diagnostics.
-
Geoffrey Riley
Clinical Professor, Radiology
Current Research and Scholarly InterestsMSK tumors, sarcomas, bone tumors, soft tissue tumors.
-
Raheleh Roudi
Basic Life Research Scientist, Rad/Pediatric Radiology
BioRaheleh Roudi is a research scientist in the Department of Radiology at Stanford University. Dr. Roudi trained at the Iran University of Medical Sciences, Iran. She worked as an Assistant Professor at the Iran University of Medical Sciences, Iran from 2015 to 2019, before coming to the United States. During this time, Dr. Roudi worked on several projects which have led to successful collaborations with the Karolinska Institute; Charite Universitatsmedizin Berlin; Oslo University Hospital; National University of Singapore; Shanghai University of Traditional Chinese Medicine and University of Brescia, among other internationally recognized institutions.
Dr. Roudi was a visiting scientist in the University of Texas at San Antonio and then appointed as a postdoctoral associate at the University of Minnesota for one year, before joining Stanford University in 2022.
Her research interest focuses on the molecular oncology and immunotherapies of solid tumors and she published more than 40 peer reviewed papers.
